Effectiveness and safety of baricitinib in patients with severe alopecia areata: a 36-week multicenter real-world experience
Luigi Gargiulo, Luciano Ibba, Carlo Alberto Vignoli, Silvia Mariel Ferrucci, Santo Raffaele Mercuri, Piergiorgio Malagoli, Angelo Valerio Marzano, Mauro Barbareschi, Vittoria Giulia Bianchi, Mario Valenti, Antonio Costanzo, Alessandra Narcisi
Abstract
Dear Editor,Alopecia areata (AA) is a chronic immune-mediated disorder characterized by non-scarring hair loss that can involve any hair-bearing site (1,2). AA pathogenesis depends on dysregulation...
Topics & Concepts
MedicineAlopecia areataDermatologyMulticenter studySurgeryRandomized controlled trialHair Growth and DisordersAutoimmune Bullous Skin DiseasesAutoimmune and Inflammatory Disorders